Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Brain Motor Network Changes in Parkinson's Disease: Evidence from Meta-Analytic Modeling

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Paroxysmal Cranial Dyskinesia and Nail-Patella Syndrome Caused by a Novel Variant in the LMX1B Gene

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Sensorimotor subthalamic stimulation restores risk-reward trade-off in Parkinson's disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Automatic quantification of micro‐sleep stability in isolated REM sleep behavior disorder and Parkinson's disease

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  1. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cerebrospinal fluid and plasma distribution of anti-α-synuclein IgMs and IgGs in multiple system atrophy and Parkinson's disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Exploring Movement Impairments in Patients With Parkinson's Disease Using the Microsoft Kinect Sensor: A Feasibility Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Author Correction: Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Vis graf over relationer

Background: MicroRNAs are small noncoding RNAs involved in the post-transcriptional regulation of protein synthesis. Extracellular microRNAs are accessible in a stable form in biofluids. Objectives: The aim was to identify individual microRNAs and/or subsets of microRNAs in CSF with biomarker potential and thus identify specific putative pathophysiological pathways. Methods: In a two-step exploratory study design of PD, MSA, PSP, and controls, we initially profiled CSF microRNAs in a pilot cohort (n = 40) by screening for 372 microRNAs. Subsequently, we attempted to validate findings in an independent study cohort in CSF (n = 118) and ethylenediaminetetraacetic acid plasma (n = 114). This study cohort encompassed 46 microRNAs, of which 26 were singled out from the pilot cohort, and an additional 20 microRNAs were added based on previous publications. The most accurate diagnostic microRNA classifiers were identified in a multivariable logistic regression model adjusted for age and sex. Results: A set of three microRNAs in CSF discriminated PD and MSA from controls with good diagnostic accuracy by receiver operating characteristics curve evaluation. The microRNAs were for PD versus controls: miR-7-5p, miR-331-5p, and miR-145-5p (area under the curve = 0.88) and MSA versus controls: miR-7-5p, miR-34c-3p, and miR-let-7b-5p (area under the curve = 0.87). The classifier that best distinguished MSA and PD consisted of two microRNAs: miR-9-3p and miR-106b-5p (area under the curve = 0.73). A single microRNA, miR-106b-5p, provided the best discrimination between PD and PSP (area under the curve = 0.85) in the CSF. Conclusions: Levels of specific trios of CSF-microRNAs discriminate well between α-synucleinopathies (PD and MSA) and controls. The results need to be validated in larger, independent cohorts.

OriginalsprogEngelsk
TidsskriftMovement disorders : official journal of the Movement Disorder Society
Vol/bind34
Udgave nummer2
Sider (fra-til)246-254
Antal sider9
ISSN0885-3185
DOI
StatusUdgivet - feb. 2019

ID: 56595169